IRIDEX
Open
$1.14
Prev. Close
$1.14
High
$1.14
Low
$1.12
Market Snapshot
$19.38M
-5.9
-0.54
$48.67M
93
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The firm is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The firm is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Recently from Cashu

IRIDEX Reports Q1 2026 Results: Positive EBITDA Amid Revenue Decline and Industry Challenges
IRIDEX Corporation (Ticker: IRIX) continues to navigate the complexities of the medical technology sector, reporting its Q1 2026 financial results amid various industry challenges. Fiscal Performance…
IRIDEX: Innovating Eye Care Solutions in a Competitive Medical Device Landscape
IRIDEX's Strategic Position in the Evolving Medical Device Landscape IRIDEX Corporation, a key player in the medical device industry, focuses on developing innovative solutions for eye care and aesthe…
IRIDEX Stock Analysis: Insights and Updates on Performance and Market Trends
Please provide the content you would like me to summarize, and I will be happy to help!
IRIDEX Stock Update: Key Insights and Market Trends
Please provide the text you would like me to summarize, and I will be happy to help!